计算药物重定位发现他汀类可能预防黑色素瘤转移
该研究通过Connectivity Map药物重定位筛选发现他汀类可能预防黑色素瘤转移,体外实验显示氟伐他汀处理A375细胞后转移相关基因表达改变,475例患者病历回顾显示服用他汀者诊断时转移率较低(24.7% vs 37.6%,绝对风险降低12.9%,P=0.038),提示他汀可能预防黑色素瘤转移但需前瞻性试验验证。
要点
- 他汀类经计算药物重定位筛选被识别为可能预防黑色素瘤转移的药物类别
- 回顾性病历分析中服用他汀者黑色素瘤诊断时转移率较低(24.7% vs 37.6%,P=0.038)
- 该发现仅为回顾性证据,尚需前瞻性试验验证其预防转移的作用及机制
核心结论
- 他汀类可能作为预防黑色素瘤转移的治疗药物,但需前瞻性试验验证。
研究设计与样本
- 利用Connectivity Map进行计算机药物筛选。
- 对氟伐他汀处理的A375细胞进行RNA测序以描述转录组变化。
- 回顾性分析475例黑色素瘤患者的病历资料。
主要发现
- 他汀类诱导与转移相关的基因差异表达,这些基因用于商业可得的黑色素瘤转移预后检测。
- 服用他汀的患者在黑色素瘤诊断时转移概率较低(24.7% vs 37.6%,绝对风险降低12.9%,P=0.038),单因素和多因素分析均显著。
关键数值与推荐
- 服用他汀者诊断时转移率为24.7%,未服用者为37.6%,绝对风险降低12.9%,P=0.038。
临床怎么用
- 目前不建议仅基于此回顾性证据改变临床实践,他汀用于预防黑色素瘤转移需等待前瞻性试验结果。
局限性
- 研究为回顾性病历分析,可能存在混杂因素。
- 体外实验仅使用A375细胞系,机制尚未明确。
- 需前瞻性试验验证发现并确定预防转移的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite advances in melanoma treatment, more than 70% of patients with distant metastasis die within 5 years. Proactive treatment of early melanoma to prevent metastasis could save lives and reduce overall healthcare costs. Currently, there are no treatments specifically designed to prevent early melanoma from progressing to metastasis. We used the Connectivity Map to conduct an in silico drug screen and identified 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) as a drug class that might prevent melanoma metastasis. To confirm the in vitro effect of statins, RNA sequencing was completed on A375 cells after treatment with fluvastatin to describe changes in the melanoma transcriptome. Statins induced differential expression in genes associated with metastasis and are used in commercially available prognostic tests for melanoma metastasis. Finally, we completed a chart review of 475 patients with melanoma. Patients taking statins were less likely to have metastasis at the time of melanoma diagnosis in both univariate and multivariate analyses (24.7% taking statins vs. 37.6% not taking statins, absolute risk reduction = 12.9%, P = 0.038). These findings suggest that statins might be useful as a treatment to prevent melanoma metastasis. Prospective trials are required to verify our findings and to determine the mechanism of metastasis prevention.
引用
- Yu WY, Hill ST, Chan ER, et al. Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma. J Invest Dermatol. 2021. PMID: 33417917. doi:10.1016/j.jid.2020.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。